Kevin J.  Knopp net worth and biography

Kevin Knopp Biography and Net Worth

CEO of 908 Devices
Dr. Kevin Knopp is a co-founder & CEO of 908 Devices Inc. An experienced high-tech entrepreneur, Kevin co-founded Ahura Scientific in 2002, and was Senior Vice President overseeing Operations, R&D and Safety and Security Sales through Ahura’s acquisition by Thermo Fisher Scientific in 2010, where he continued as Vice-President and Site Leader of the Portable Optical Analysis division. Kevin served as an independent board member for Crystal IS until its acquisition by Asahi-Kasei. He earned B.S.E.E from Boston University, M.S.E.E, and Ph.D. degrees in Optics from the University of Colorado. Kevin is an inventor on more than 20 US patents, is an author on more than a dozen refereed publications, and his products have received R&D 100, Business Week IDEA, GSN, CPhI Gold, Cygnus, and Frost & Sullivan awards.

What is Kevin J. Knopp's net worth?

The estimated net worth of Kevin J. Knopp is at least $1.05 million as of May 13th, 2024. Dr. Knopp owns 508,981 shares of 908 Devices stock worth more than $1,048,501 as of December 22nd. This net worth approximation does not reflect any other assets that Dr. Knopp may own. Additionally, Dr. Knopp receives an annual salary of $761,120.00 as CEO at 908 Devices. Learn More about Kevin J. Knopp's net worth.

How old is Kevin J. Knopp?

Dr. Knopp is currently 51 years old. There are 5 older executives and no younger executives at 908 Devices. Learn More on Kevin J. Knopp's age.

What is Kevin J. Knopp's salary?

As the CEO of 908 Devices Inc., Dr. Knopp earns $761,120.00 per year. Learn More on Kevin J. Knopp's salary.

How do I contact Kevin J. Knopp?

The corporate mailing address for Dr. Knopp and other 908 Devices executives is , , . 908 Devices can also be reached via phone at 857-254-1500 and via email at [email protected]. Learn More on Kevin J. Knopp's contact information.

Has Kevin J. Knopp been buying or selling shares of 908 Devices?

Kevin J. Knopp has not been actively trading shares of 908 Devices during the last quarter. Most recently, on Monday, May 13th, Kevin J. Knopp bought 10,000 shares of 908 Devices stock. The stock was acquired at an average cost of $6.42 per share, with a total value of $64,200.00. Following the completion of the transaction, the chief executive officer now directly owns 508,981 shares of the company's stock, valued at $3,267,658.02. Learn More on Kevin J. Knopp's trading history.

Who are 908 Devices' active insiders?

Are insiders buying or selling shares of 908 Devices?

In the last year, 908 Devices insiders bought shares 3 times. They purchased a total of 30,000 shares worth more than $178,500.00. In the last year, insiders at the sold shares 3 times. They sold a total of 20,001 shares worth more than $139,954.68. The most recent insider tranaction occured on May, 13th when CEO Kevin J Knopp bought 10,000 shares worth more than $64,200.00. Insiders at 908 Devices own 27.7% of the company. Learn More about insider trades at 908 Devices.

Information on this page was last updated on 5/13/2024.

Kevin J. Knopp Insider Trading History at 908 Devices

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2024Buy10,000$6.42$64,200.00508,981View SEC Filing Icon  
5/9/2024Buy10,000$5.83$58,300.00488,981View SEC Filing Icon  
5/7/2024Buy10,000$5.60$56,000.00468,981View SEC Filing Icon  
2/1/2024Sell9,071$7.00$63,497.00411,981View SEC Filing Icon  
2/15/2023Sell15,158$10.29$155,975.82432,690View SEC Filing Icon  
2/1/2023Sell4,049$9.36$37,898.64487,848View SEC Filing Icon  
10/17/2022Sell11,200$14.68$164,416.00519,442View SEC Filing Icon  
9/15/2022Sell30,000$16.94$508,200.00530,642View SEC Filing Icon  
8/1/2022Sell14,647$22.46$328,971.62616,838View SEC Filing Icon  
7/28/2022Sell5,700$22.01$125,457.00649,485View SEC Filing Icon  
7/21/2022Sell200$22.04$4,408.00655,185View SEC Filing Icon  
7/15/2022Sell30,000$17.37$521,100.00655,385View SEC Filing Icon  
7/8/2022Sell453$22.06$9,993.18685,385View SEC Filing Icon  
7/6/2022Sell1,000$22.07$22,070.00685,838View SEC Filing Icon  
6/21/2022Sell9,200$15.07$138,644.00686,838View SEC Filing Icon  
11/1/2021Sell20,000$34.62$692,400.00View SEC Filing Icon  
10/1/2021Sell20,000$33.65$673,000.00View SEC Filing Icon  
See Full Table

Kevin J. Knopp Buying and Selling Activity at 908 Devices

This chart shows Kevin J Knopp's buying and selling at 908 Devices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

908 Devices Company Overview

908 Devices logo
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $2.06
Low: $1.90
High: $2.07

50 Day Range

MA: $2.85
Low: $1.88
High: $3.91

2 Week Range

Now: $2.06
Low: $1.82
High: $12.51

Volume

620,209 shs

Average Volume

213,737 shs

Market Capitalization

$71.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92